Provider of high-frequency COVID-19 and respiratory pathogen testing platform. The company has AMPD nanopore sequencing and a machine learning-powered platform. It is used for the diagnostics of covid-19, influenza, and respiratory pathogens.
← All startups
Angstrom
Series AProvider of high-frequency COVID-19 and respiratory pathogen testing platform. The company has AMPD nanopore sequencing and a machine learning-powered platform. It is used for the diagnostics of covid-19, influenza, and respiratory pathogens.
About
Institutional investors
GreyBird Ventures
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.